Illumina (ILMN) PT Raised to $110 at Barclays
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts ILMN Hot Sheet
Price: $226.54 --0%
Rating Summary:
18 Buy, 20 Hold, 6 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 16 | New: 2
Rating Summary:
18 Buy, 20 Hold, 6 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 16 | New: 2
Join SI Premium – FREE
Barclays analyst Luke Sergott raised the price target on Illumina (NASDAQ: ILMN) to $110.00 (from $100.00) while maintaining a Underweight rating.
You May Also Be Interested In
- Illumina selected to help bring precision medicine into everyday healthcare in Singapore
- BB Seguridade (BBSE3:BZ) (BBSEY) PT Lowered to BRL33 at JPMorgan
- ADMA Biologics (ADMA) PT Raised to $18 at Mizuho
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
